LSP BioVentures

LSP BioVentures was a venture capital firm specializing in the life sciences sector, serving as the North American investment arm of the European firm Life Sciences Partners (LSP). The firm focused on providing capital to early- and growth-stage companies developing innovative therapeutics, medical devices, and diagnostics. With offices in Cambridge, Massachusetts, and Amsterdam, the firm leveraged a deep scientific and clinical network to identify high-potential investment opportunities. In 2022, LSP was acquired by the global investment organization EQT for approximately €450 million and integrated into its platform as EQT Life Sciences. The firm's investment strategy emphasized high-science opportunities with the potential to address significant unmet medical needs across various therapeutic areas.